Jinhai Medical Technology Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Zhenfei Wang
Chief executive officer
S$1.0m
Total compensation
| CEO salary percentage | 34.65% |
| CEO tenure | 5.8yrs |
| CEO ownership | n/a |
| Management average tenure | 1.8yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
Jinhai Medical Technology Limited's (HKG:2225) Share Price Is Still Matching Investor Opinion Despite 28% Slump
Jan 30
Jinhai Medical Technology Limited's (HKG:2225) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Dec 16Jinhai Medical Technology (HKG:2225) Has Debt But No Earnings; Should You Worry?
Nov 05Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price
Oct 06The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon
Jun 19Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%
May 13Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%
Mar 17What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You
Jan 31Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital
Jun 06Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital
Mar 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | S$1m | S$351k | -S$18m |
| Sep 30 2024 | n/a | n/a | -S$14m |
| Jun 30 2024 | n/a | n/a | -S$10m |
| Mar 31 2024 | n/a | n/a | -S$7m |
| Dec 31 2023 | S$111k | S$108k | -S$3m |
| Sep 30 2023 | n/a | n/a | -S$2m |
| Jun 30 2023 | n/a | n/a | S$6k |
| Mar 31 2023 | n/a | n/a | S$237k |
| Dec 31 2022 | S$240k | S$237k | S$468k |
| Sep 30 2022 | n/a | n/a | S$443k |
| Jun 30 2022 | n/a | n/a | S$419k |
| Mar 31 2022 | n/a | n/a | S$86k |
| Dec 31 2021 | S$356k | S$353k | -S$246k |
| Sep 30 2021 | n/a | n/a | S$320k |
| Jun 30 2021 | n/a | n/a | S$852k |
| Mar 31 2021 | n/a | n/a | S$1m |
| Dec 31 2020 | S$365k | S$362k | S$1m |
| Sep 30 2020 | n/a | n/a | S$516k |
| Jun 30 2020 | n/a | n/a | -S$231k |
| Mar 31 2020 | n/a | n/a | -S$459k |
| Dec 31 2019 | S$362k | S$161k | -S$686k |
Compensation vs Market: Zhenfei's total compensation ($USD779.40K) is above average for companies of similar size in the Hong Kong market ($USD443.45K).
Compensation vs Earnings: Zhenfei's compensation has increased whilst the company is unprofitable.
CEO
Zhenfei Wang (42 yo)
5.8yrs
Tenure
S$1,013,000
Compensation
Mr. Zhenfei Wang has been Chief Executive Officer and Executive Director of Jinhai Medical Technology Limited (formerly known as Jinhai International Group Holdings Limited) (formerly known as Kakiko Group...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 5.8yrs | S$622.00k | 48.94% HK$ 3.2b | |
| CEO & Executive Director | 5.8yrs | S$1.01m | no data | |
| Executive Director | 1.8yrs | S$87.00k | no data | |
| Chief Financial Officer | 5.5yrs | no data | no data | |
| Chief Technical Officer | 1.4yrs | no data | no data | |
| Chief Marketing Officer | less than a year | no data | no data | |
| Company Secretary | 1.1yrs | no data | no data |
1.8yrs
Average Tenure
50.5yo
Average Age
Experienced Management: 2225's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 5.8yrs | S$622.00k | 48.94% HK$ 3.2b | |
| CEO & Executive Director | 5.8yrs | S$1.01m | no data | |
| Executive Director | 5.8yrs | S$87.00k | no data | |
| Non-Executive Vice-Chairman | 5.8yrs | S$19.90k | no data | |
| Non-Executive Director | 5.8yrs | S$33.00k | no data | |
| Independent Non-Executive Director | 5.8yrs | S$21.00k | no data | |
| Independent Non-Executive Director | 5.8yrs | S$21.00k | no data | |
| Independent Non-Executive Director | 3.3yrs | S$21.00k | no data |
5.8yrs
Average Tenure
53.5yo
Average Age
Experienced Board: 2225's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/17 16:52 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jinhai Medical Technology Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.